ZOSBIO CE Troponin I Detection Reagent Myocardial Injury Detection Protein

CTnI Overview

Cytokinin I (cTnI) is a special protein originated from cardiomyocytes. It has extraordinary function to control the contraction of cardiomyocytes. It is widely used in clinical detection of myocardial injury and unstable angina pectoris. For these patients, cTnI has the advantages of early onset, persistence, myocardial specificity and long diagnostic cycle. It is the first choice for the diagnosis of myocardial infarction.

CTnI Performance Index

CTnI Clinical Significance

Thrombin combined with ischemic evidence is helpful for the early diagnosis and treatment of type I myocardial infarction. Mastering the change law of exocrin is helpful to identify and diagnose exocrin. For example, for temporary myocardial injury caused by strenuous exercise, tachycardia and acute pulmonary embolism, CTN will temporarily increase and return to normal within 1-2 days. Chronic CTN elevation is caused by heart failure. These characteristics can help us distinguish myocardial infarction.

• Preferred marker of myocardial infarction (MI)
• We measured the size of the infarct and stratified the risk.
• Prognosis of patients with AMI

Access to diagnosis and risk stratification of ACS (ESC guidelines 2007)

See a doctor	Chest pain/chest tightness
Medical history and physical examination	Suspected ACS (Acute Coronary Syndrome)
electrocardiogram	Persistent ST segment elevation	Abnormal St/T segment ↓		ECG normal ↓
Biochemical test	↓Confirm	CTN was positive		Troponin CTN negative ×2
Risk stratification		high-risk		Low risk
diagnosis	ST-segment elevation myocardial infarction STEMI	Non-ST-segment elevation myocardial infarction NSTEMI		Unstable angina pectoris UA
treatment	Reperfusion	Interventional therapy		Non-interventional therapy

CTnI Advantages of clinical application

• Smaller molecular weight and longer time
• It is closely related to the degree of victimization

CTnI Reference

Ctnt<0.1 μg/L was normal, >0.2 μg/L was diagnostic off, and >0.5 μg/L was diagnosed as acute myocardial infarction. CTnI<0.2 μg/L was the normal value, and >1.5 μg/L was the closed value of ELISA diagnosis.

Application Department

Cardiology, first aid, examination room, pediatrics, hematology, oncology, Nephrology, surgery, etc

cTnI Clinical comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.